Peña Javier, Rada Gabriel
Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Proyecto Epistemonikos, Santiago, Chile. Email:
Proyecto Epistemonikos, Santiago, Chile; Programa de Salud Basada en Evidencia, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; Departamento de Medicina Interna, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; GRADE working group; The Cochrane Collaboration.
Medwave. 2017 Jan 13;17(Suppl1):e6821. doi: 10.5867/medwave.2017.6821.
Several beneficial effects have been proposed for cannabinoids in different clinical conditions, including epilepsy. However, their clinical role is controversial. Searching in Epistemonikos database, which is maintained by screening multiple databases, we identified five systematic reviews including four randomized trials addressing the question of this article. We extracted data and generated a summary of findings following the GRADE approach. We concluded it is not clear whether cannabinoids reduce the frequency of seizures in epilepsy because the certainty of the evidence is very low, and they probably increase adverse effects.
大麻素在包括癫痫在内的不同临床病症中已被提出有多种有益作用。然而,它们的临床作用存在争议。通过检索由筛选多个数据库维护的Epistemonikos数据库,我们识别出五项系统评价,其中包括四项针对本文问题的随机试验。我们提取数据并按照GRADE方法生成了研究结果总结。我们得出结论,尚不清楚大麻素是否能降低癫痫发作频率,因为证据的确定性非常低,而且它们可能会增加不良反应。